Refining the management of relapsed or refractory follicular lymphoma: case scenarios
Clin Adv Hematol Oncol
.
2020 Dec;18 Suppl 20(12):20-21.
Authors
John M Pagel
1
,
John M Burke
2
,
Lori A Leslie
3
4
5
Affiliations
1
Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, Washington.
2
US Oncology Hematology Research Program, Rocky Mountain Cancer Centers, Aurora, Colorado.
3
John Theurer Cancer Center, Hackensack, New Jersey.
4
Mountainside Medical Center, Montclair, New Jersey.
5
Hackensack Meridian Health, Hackensack, New Jersey.
PMID:
33843897
No abstract available
MeSH terms
Antineoplastic Combined Chemotherapy Protocols
Humans
Lymphoma, Follicular* / diagnosis
Lymphoma, Follicular* / drug therapy
Recurrence
Rituximab / therapeutic use
Substances
Rituximab